The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Classification system and case definition for SARS‐CoV‐2 infection in pregnant women, fetuses, and neonates
Open accessAbstract
The possibility of mother-to-fetus transmission of SARS-CoV-2, the cause of coronavirus disease 2019 (COVID-19), is currently a highly debated concept in perinatal medicine.1 It has implications for the mother, fetus, and neonate, as well as for healthcare providers present at the time of birth and caring for the child during the neonatal period, including obstetricians, midwives, family doctors, anesthetists, pediatricians, neonatologists, nurses, and respiratory therapists. At present the evidence for intrauterine transmission from mother to fetus or intrapartum transmission from mother to the neonate is sparse. There are limitations associated with sensitivity and specificity of diagnostic tests used and classification of patients based on test results has also been questioned.2-7 As a result, differing recommendations have emerged regarding which samples should be collected and when, and how to distinguish infection from contamination,8-11 making it difficult for clinicians “on the ground” to know which recommendations to follow.12 Additionally, a woman could be infected at any time during pregnancy and the impact on the fetus when maternal infection occurs earlier in pregnancy may be different than when it occurs in the two weeks prior to delivery. Infection during the first or second trimester has the potential to cause miscarriage, preterm birth, birth defects or possibly other features of congenital infection. In late gestation maternal infection, we need to consider the possibility that the newborn could have active infection and consequently at risk of adverse outcomes and also that the infant could pose a risk to healthcare workers. Therefore, in this paper, we focus solely on newborn infants whose mothers have documented or suspected COVID-19 at the time of onset of labor and delivery. Fortunately, the majority of neonates born to mothers with SARS-CoV-2 infection either do not become infected or exhibit mild symptoms at birth. However, the fact that a significant proportion of maternal and neonatal infections can be asymptomatic creates difficulty in ascertaining the disease burden on neonates and the possibility of transmission to healthcare providers during resuscitation or admission to a unit. Unequivocal diagnosis of most fetal or neonatal infections is typically made by detection of the organism in culture or by nucleic acid amplification tests that identify the presence of the pathogen's RNA or DNA in amniotic fluid prior to onset of labor or in properly collected fetal/neonatal blood or body fluid samples, or by histopathological demonstration of the organism in fetal/neonatal tissues. Serology plays an important role in diagnosis for certain congenital infections such as toxoplasmosis and syphilis. The role of serology in the diagnosis of SARS-CoV-2 infection is still uncertain and consequently it is difficult to envision how serology may contribute to newborn diagnosis – especially when maternal infection occurs late in pregnancy and there may not have been sufficient time for antibodies to be generated. Until there is a clear understanding of appropriate diagnostic methods and interpretation of results for newborn infants, a detailed classification system is likely to be helpful. Such a system could aid healthcare practitioners in evaluating patients, determining appropriate infection control measures, planning appropriate follow-up for neonates and infants, allowing large epidemiological studies and helping collaboration between international efforts to learn about potential effects of maternal infections. In this paper, we present such a classification. In developing this system, we adopted an approach similar to Lebech et al13 in creating five mutually exclusive categories of the likelihood of infection: (a) confirmed, (b) probable, (c) possible, (d) unlikely, and (e) not infected. The first and last categories (confirmed and not infected) are to be considered absolute and confirmatory. The probable category denotes strong evidence of infection but a lack of absolute proof. The possible category denotes evidence that is suggestive of infection but is incomplete. The unlikely category applies when there is little support for a diagnosis, but infection cannot be completely ruled out. Notably, a case may be initially assigned to one category and later moved to another category as more information is available. All five categories will not be applicable to all types of infections. We have avoided terminology such as ‘vertical’ or ‘horizontal transmission’ and rather developed a system that classifies transmission as congenital infection in intrauterine death/ stillbirth, congenital infection in live born, neonatal infection acquired intrapartum, or neonatal infection acquired postnatally,14 which aligns with the actual pathological process as opposed to unknown directions of transmission.15 Our classification system is presented in Table 1. Currently, the classification system takes in
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schwartz, D. A. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0901-sa · Cited by 976
Cited by
Knight, M., Bunch, K., Vousden, N., Morris, E., Simpson, N., Gale, C., O’Brien, P., Quigley, M., Brocklehurst, P., & Kurinczuk, J. J. (2020) · BMJ · doi:10.1136/bmj.m2107 · Cited by 1,170
Transplacental transmission of SARS-CoV-2 infection
Vivanti, A. J., Vauloup-Fellous, C., Prevot, S., Zupan, V., Suffee, C., Do Cao, J., Benachi, A., & De Luca, D. (2020) · Nature Communications · doi:10.1038/s41467-020-17436-6 · Cited by 1,103
An update on COVID-19 and pregnancy
Jamieson, D. J., & Rasmussen, S. A. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.08.054 · Cited by 466
Analysis of SARS-CoV-2 vertical transmission during pregnancy
Fenizia, C., Biasin, M., Cetin, I., Vergani, P., Mileto, D., Spinillo, A., Gismondo, M. R., Perotti, F., Callegari, C., Mancon, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18933-4 · Cited by 361
Kirtsman, M., Diambomba, Y., Poutanen, S. M., Malinowski, A. K., Vlachodimitropoulou, E., Parks, W. T., Erdman, L., Morris, S. K., & Shah, P. S. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200821 · Cited by 334
Self-citation
Metadata
- Authors
- Shah, P. S., Diambomba, Y., Acharya, G., Morris, S. K., & Bitnun, A.
- Venue
- Acta Obstetricia et Gynecologica Scandinavica
- Publisher
- Wiley
- Published
- 2020-04-21
- Volume
- 99
- Issue
- 5
- Pages
- 565-568
- ISSN
- 0001-6349 (ISSN-L)
- 1600-0412
- OpenAlex
- W3015493153
- Cited by
- 225
- References
- 1
- FWCI
- 27.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Classification system and case definition for SARS‐CoV‐2 infection in pregnant women, fetuses, and neonates. https://app.cochat.ai/papers/10.1111/aogs.13870
- The paper
- Shah, P. S., Diambomba, Y., Acharya, G., Morris, S. K., & Bitnun, A. (2020). Classification system and case definition for SARS‐CoV‐2 infection in pregnant women, fetuses, and neonates. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.13870
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.